Patents/Assignees

Cartesian Therapeutics, Inc.

5 patents in portfolio

US12553041utility2026
Formulations and Doses of Pegylated Uricase
0 cites
US12508249utility2025
Methods Related to Administering Immunosuppressants and Non-allergenic Antigens to Reduce or Prevent Anaphylaxis
0 cites
US12472167utility2025
Methods Providing a Therapeutic Macromolecule and Synthetic Nanocarriers Comprising Immunosuppressant Locally and Concomitantly to Reduce Both Type 1 and Type IV Hypersensitivity
0 cites
US12194078utility2025
Methods and Compositions Related to Combined Treatment with Anti-inflammatories and Synthetic Nanocarriers Comprising an Immunosuppressant
0 cites
US11999773utility2024
Anti-bcma Chimeric Antigen Receptors
0 cites